GLP-1 and Constipation: Why It Happens and How to Fix It
Constipation affects up to 24% of people on GLP-1 medications like semaglutide and tirzepatide — making it one of the most common side effects that rarely gets discussed openly. Here's exactly why it happens, which remedies work, which ones make it worse, and when to contact your provider.
Key takeaways
Constipation affects 6–24% of GLP-1 patients and is listed in FDA prescribing information for both semaglutide and tirzepatide.
The cause is reduced colonic motility — GLP-1 receptors throughout the gut slow transit when activated by these medications.
Hydration is the most impactful fix — GLP-1 medications blunt thirst signals and reduce food-derived water, compounding the problem.
Fiber without enough water can make constipation worse — always increase both together.
For most patients, symptoms improve once the dose stabilizes — typically within 2–4 weeks at each new dose level.
Why GLP-1 medications cause constipation
GLP-1 receptor agonists like semaglutide and tirzepatide work partly by slowing gastric emptying — the rate at which food moves from your stomach into your small intestine. This is what creates the prolonged fullness that drives weight loss. But the slowdown doesn't stop in the stomach.
GLP-1 receptors are present throughout the entire gastrointestinal tract, including the intestines and colon. When activated, they reduce colonic motility — the muscular contractions that move stool through and out of the body. Less movement means stool sits longer, loses more water, and becomes harder and more difficult to pass.
Three factors that compound the problem
1. Reduced food intake. Less food means less bulk moving through the colon, which slows transit further even before the medication's direct effects on gut motility.
2. Reduced water from food. Roughly 20–30% of daily water intake typically comes from food. When GLP-1 dramatically suppresses appetite, this hidden water source disappears — leading to drier, harder-to-pass stool.
3. Blunted thirst signals. GLP-1 medications can reduce thirst cues, meaning patients drink less water without realizing it. This compounds the dehydration effect and is one of the most underrecognized contributors to constipation on these medications.
When is it worst?
Constipation is most pronounced during dose escalation — the weeks immediately following a dose increase. As your dose steps up from 2.5mg to 5mg to 7.5mg and beyond, colonic motility slows further with each increase, and the gut needs 1–2 weeks to adapt.
Once you stabilize at a maintenance dose, constipation typically improves significantly. Patients who manage hydration and fiber proactively from the beginning of treatment report considerably milder symptoms throughout.
What actually works — step by step
Step 1: Hydrate intentionally
This is the single most impactful change. Because GLP-1 medications blunt thirst cues and reduce food-derived water, you must drink deliberately — not just when you feel thirsty. Target at least 64–80 oz (8–10 cups) of water daily, more if you're active or in a warm climate.
A practical system: drink a full glass of water first thing in the morning, one before each meal, and one before bed. This typically gets most patients close to the daily target without counting.
Critical note: If you increase fiber (step 2) without also increasing water, you add bulk without improving passage — which can make constipation worse, not better.
Step 2: Increase fiber — gradually
Target 25–35 grams of fiber per day from food and, if needed, supplements. The keyword is gradually — jumping from low fiber to high fiber overnight commonly causes bloating and discomfort. Increase by 3–5 grams per week.
High-fiber foods that work well alongside a reduced GLP-1 appetite: chia seeds (10g per 2 tbsp), avocado (10g per whole), raspberries (8g per cup), lentils (15g per cup cooked), and oats (4g per cup cooked).
If food isn't providing enough, a daily psyllium husk supplement (Metamucil) is well-studied. Start with one teaspoon per day and increase slowly.
Step 3: Move your body daily
Physical movement directly stimulates gut motility. Even a 15–20 minute walk after meals can meaningfully speed up colonic transit. This is especially important on GLP-1 therapy because reduced appetite often leads to reduced overall movement — compounding the constipation cycle.
Step 4: Don't let intake drop too low
Extremely low calorie intake dramatically slows gut motility. Even when you're not hungry, aim for at least 3 small meals daily with adequate protein and some fiber at each. Skipping meals entirely for extended periods worsens constipation and increases the risk of nutritional deficiencies.
Step 5: Use laxatives strategically if needed
Osmotic laxatives (MiraLax, milk of magnesia) draw water into the colon and soften stool. Generally safe, non-habit-forming, and commonly recommended as a first-line option for GLP-1-related constipation.
Stool softeners (Colace) add moisture to stool. Safe for ongoing use alongside other strategies.
Magnesium citrate or magnesium oxide are gentle osmotic options many GLP-1 patients tolerate well. Talk to your provider about dosing.
Avoid stimulant laxatives (Ex-Lax, Dulcolax) for regular use. They work by forcing muscle contractions and can create dependence over time, making the underlying motility problem worse rather than better.
What to avoid
When to contact your provider
Most GLP-1-related constipation is mild to moderate and responds to the strategies above. Contact your Ondra provider through the patient portal if you experience:
- No bowel movement for more than 7 days despite dietary changes
- Severe abdominal pain or cramping
- Nausea or vomiting accompanied by constipation
- Blood in stool
- Constipation significantly affecting your daily quality of life
These may warrant a dose review, a slower titration pace, or clinical evaluation to rule out other causes.
Frequently asked questions
Do GLP-1 medications cause constipation?
Yes. Constipation is a recognized side effect listed in FDA prescribing information for both semaglutide (Wegovy) and tirzepatide (Zepbound). Clinical trials show it affects approximately 6–24% of patients. The primary cause is reduced colonic motility from GLP-1 receptor activation throughout the gut.
How do I relieve constipation on semaglutide or tirzepatide?
The most effective strategies are: drinking at least 64–80 oz of water daily (intentionally, since GLP-1 medications blunt thirst cues), gradually increasing fiber intake to 25–35g per day, staying physically active, and using osmotic laxatives like MiraLax or magnesium citrate if dietary changes aren't enough. Avoid stimulant laxatives for regular use.
Will constipation from GLP-1 medications go away?
For most patients, yes. Constipation is most pronounced during dose escalation and typically improves once the body adapts to a stable dose — usually within 2–4 weeks. Patients who proactively manage hydration and fiber from the start report significantly milder symptoms throughout treatment.
When should I contact my provider about constipation on GLP-1?
Contact your provider if you go more than 7 days without a bowel movement despite dietary changes, experience severe abdominal pain, notice blood in your stool, or have constipation accompanied by nausea or vomiting. These symptoms may warrant a dose review or clinical evaluation.
Is constipation worse on tirzepatide than semaglutide?
Individual responses vary. Tirzepatide's dual GIP/GLP-1 mechanism can affect gut motility more in some patients than semaglutide's single GLP-1 mechanism. Both medications carry similar rates of constipation in clinical trials, and management strategies are the same for both.
† This article is for educational purposes only and does not constitute medical advice. Always consult your licensed healthcare provider before starting any supplement or laxative alongside your prescription medication. Constipation rates cited from FDA prescribing information for Wegovy (semaglutide) and Zepbound (tirzepatide) and referenced clinical trial data.